Intrexon Corp (XON)

27.41
NYSE : Health Care
Prev Close 28.04
Day Low/High 27.39 / 28.26
52 Wk Low/High 18.52 / 45.90
Avg Volume 1.50M
Exchange NYSE
Shares Outstanding 118.33M
Market Cap 3.32B
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Intrexon To Develop Disease-Modifying Therapies In New Collaborations With Harvest Intrexon Enterprise Fund

Intrexon To Develop Disease-Modifying Therapies In New Collaborations With Harvest Intrexon Enterprise Fund

Startups to Utilize ActoBiotics™ Platform to Develop Innovative Treatments for Celiac Disease and Chronic Rhinosinusitis

'Mad Money' Lightning Round: Buy, Buy, Buy Macy's

'Mad Money' Lightning Round: Buy, Buy, Buy Macy's

Cramer favors Alibaba and Smith & Wesson.

Jim Cramer's 'Mad Money' Recap: Strong Demand Keeps Market From Cratering

Jim Cramer's 'Mad Money' Recap: Strong Demand Keeps Market From Cratering

Demand is quite healthy and markets are not going into the abyss, Cramer says.

Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized In Development Of New Gene Therapy Treatments

Exemplar Genetics ExeGen® Cystic Fibrosis Research Model Utilized In Development Of New Gene Therapy Treatments

Publications in Journal of Clinical Investigation demonstrate potential of ExeGen® CFTR models

Intrexon (XON) Stock Up, JMP Securities: Mosquito Authorization Could Boost Revenue

Intrexon (XON) Stock Up, JMP Securities: Mosquito Authorization Could Boost Revenue

Florida officials are pressing the government to authorize emergency use of Intrexon's (XON) genetically modified mosquitoes to combat the Zika virus.

Here's a Reason Why Intrexon (XON) Stock Is Gaining Today

Here's a Reason Why Intrexon (XON) Stock Is Gaining Today

Florida politicians issued a letter Wednesday urging the federal government to allow the state to use genetically engineered mosquitos made by Intrexon's (XON) Oxitec unit to fight the Zika virus.

How to Cash in on the Fight Against the Zika Virus

How to Cash in on the Fight Against the Zika Virus

Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.

XON: Insiders vs. Shorts

XON: Insiders vs. Shorts

The most recent short interest data was recently released for the 08/15/2016 settlement date, and Intrexon Corp is one of the most shorted stocks of the Russell 3000, based on 9.06 "days to cover" versus the median component at 5.83. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Bullish Two Hundred Day Moving Average Cross - XON

Bullish Two Hundred Day Moving Average Cross - XON

In trading on Monday, shares of Intrexon Corp crossed above their 200 day moving average of $30.42, changing hands as high as $30.56 per share. Intrexon Corp shares are currently trading up about 3.5% on the day.

4 Stocks to Buy in This Vulnerable Market

4 Stocks to Buy in This Vulnerable Market

This market is like a leaky helium balloon; watch out for sudden downdrafts.

Intrexon (XON) Weak On High Volume

Intrexon (XON) Weak On High Volume

Trade-Ideas LLC identified Intrexon (XON) as a weak on high relative volume candidate

Intrexon Introduces Florian™ Switch Technology For Flowering Control

Intrexon Introduces Florian™ Switch Technology For Flowering Control

Genetic "On-Off" Switch Promises Broad, Innovative Applications in Agriculture

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys

MIT's Smart 50 list recognizes companies for their combination of innovative technology and effective management, and it includes 13 pharmaceutical and biotech firms this year.

Intrexon (XON) Marked As A Dead Cat Bounce Stock

Intrexon (XON) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Intrexon (XON) as a "dead cat bounce" (down big yesterday but up big today) candidate

Oxitec And Piracicaba City Hall Start Downtown Release Of Friendly™ Aedes

Oxitec And Piracicaba City Hall Start Downtown Release Of Friendly™ Aedes

Expanded project begins Tuesday July 19th; Sao Judas is the first central neighbourhood to receive the mosquito that fights the primary vector of dengue, Zika and chikungunya

Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection

Brain Tumor Patient Dies After Ziopharm Gene Therapy Injection

The circumstances surrounding the Ziopharm patient deaths come amid heightened scrutiny of experimental anti-cancer therapies.

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

Ziopharm Co-Dependency Spirals Down in Amended Intrexon Deal

The amended agreement with Intrexon bolsters the bear argument against Ziopharm that its entire cancer drug pipeline is mediocre and overvalued.

Intrexon (XON) Is Today's Perilous Reversal Stock

Intrexon (XON) Is Today's Perilous Reversal Stock

Trade-Ideas LLC identified Intrexon (XON) as a "perilous reversal" (up big yesterday but down big today) candidate